PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

MDM2 inhibition improves cisplatin-induced renal injury in mice via inactivation of Notch/hes1 signaling pathway.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32856486 ↗2020Reported benefit

MDM2 inhibition improves cisplatin-induced renal injury in mice via inactivation of Notch/hes1 signaling pathway.

MouseChemical/toxinC57BL/6male

Model: Cisplatin-induced acute renal injury by intraperitoneal injection

Cisplatin raised creatinine, blood urea nitrogen, urinary cystatin C, NGAL and albumin-to-creatinine ratio, lowered glomerular filtration rate and increased tubular injury scores, MDM2, N1ICD, Hes1 and cleaved caspase-3 with a fall in the Bcl-2/Bax ratio. MDM2 inhibition improved these cisplatin-in…

Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.